Physician profile
Brandon A Bosque
NPI 1679913040
$1,820.82
in general payments reported to CMS, 2019-2025
17 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $873 · 2020: $196 · 2022: $235 · 2023: $141 · 2024: $257 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $751.81 | 2022-2025 | |
| Melinta Therapeutics, LLC | $299.50 | 2019 | |
| Smith+Nephew, INC. | $186.26 | 2019 | |
| Horizon Therapeutics Plc | $95.41 | 2019-2020 | |
| Abbvie INC. | $94.67 | 2020 | |
| Stryker Corporation | $80.71 | 2019 | |
| Integra Lifesciences Corporation | $67.24 | 2019 | |
| Osiris Therapeutics INC. | $51.30 | 2019 | |
| Zimmer Biomet Holdings, INC. | $45.48 | 2019 | |
| Misonix INC | $39.35 | 2019 | |
| Organogenesis INC. | $20.04 | 2020 | |
| Merck Sharp & Dohme LLC | $19.31 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $16.94 | 2019 | |
| Arthrosurface Incorporated | $15.33 | 2019 | |
| Ermi LLC | $14.35 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $11.65 | 2019 | |
| Pfizer INC. | $11.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Bosque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.